bioaccess®

At bioaccess®, our commitment is to empower Medtech and Biopharma innovators by accelerating early feasibility studies and first-in-human trials. We achieve this by leveraging the advantages of conducting research in Latin America, Eastern Europe, and Australia, which include approximately 40% faster approvals, 50% quicker patient enrollment, and 30% lower costs compared to the US or EU. We believe in the importance of your medical innovation and the profound benefit it could bring to people's lives. Our team is laser-focused on navigating your company through the complexities of early-stage development towards a successful acquisition. To get you there, we are committed to delivering fast, cost-effective, high-quality, and ethical clinical data.

Our mission is centered on changing lives by revolutionizing access to cutting-edge Medtech and Biopharma innovations in Latin America, Eastern Europe, and Australia. We aim to ignite hope and transform the destinies of those in need and their loved ones. Seeing the subjects we have recruited smile and be happy again, thanks to successful medical device implants or promising molecules, is a daily motivator for our team. Furthermore, when we and our clients conduct clinical studies in the countries we operate in, the impact on the local economy creates ripples with far-reaching benefits. These include creating jobs, promoting economic growth, improving healthcare, increasing research and development, and gaining international recognition. Observing our mission from a broader perspective, it is ultimately about benefiting humanity as a whole. The work we do with our associates promotes international collaboration and knowledge transfer, leading to better global health outcomes. Most importantly, it drives innovation in Medtech and Biopharma and the next generation of medical innovations.